Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Smart Vineyard Management Market - A Global and Regional Analysis: Focus on Product, Application,...
-
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons The following Director has purchased ordinary shares of 2.5 pence each in...
-
New York, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Oxygen Scavengers Market - A Global and Regional Analysis: Focus on Type, Form, End User, and Region...
-
LYON, le 05 octobre 2022 — SEIITRA, leader en solutions digitales de gestion des logements en copropriété, annonce un partenariat technologique avec Esker, plateforme cloud mondiale qui valorise les...
-
Paris, Amsterdam, October 5, 2022 Information on total number of voting rights and shares in the share capital as at September 30, 2022 (Article L.233-8-II of the French Commercial Code and Article...
-
Total number of shares and voting rights in the share capital as of August 31, 2022 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial...
-
HF COMPANYSociété Anonyme au capital de 1 569 130.50 eurosSiège social : Node Park Touraine - 37310 TAUXIGNY405 250 119 RCS TOURS Information mensuelle relative au nombre total de droits de voteet...
-
Appointment to the EDF Board of Directors The Board of Directors of EDF, meeting on 5 October 2022, took note of the appointment of Alexis Zajdenweber, Commissioner for the French State...
-
PORTLAND, Maine, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Intersolar North America (ISNA) and Energy Storage North America (ESNA), the industry’s premier solar + storage event, will offer hands-on training...
-
PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products...